Torrance, California Clinical Trials

A listing of Torrance, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
A Study to Test the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of the study is to test the efficacy and safety of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

bimekizumab
antibiotic
hidradenitis
abscess
antibiotics
Hs0004 50161
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +15 other locations
Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

A Randomized, 4-Period, Crossover Study to characterize the effects of tolperisone 200 mg and 400 mg (supratherapeutic dose) three times a day (TID) over 3 days of dosing on measures of simulated driving performance, cognitive function and drowsiness and compared to placebo and cyclobenzaprine (single-day, residual effect, multiple-day).

CNS Trial
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

body mass index
tirzepatide
dulaglutide
cardiovascular disease
Harbor UCLA Medical Center
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety …

oligoclonal bands
Investigational Site Number 8400088
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +14 other locations
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"  

Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD) Secondary Objectives: To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation To continue to assess the …

dupilumab
atopy
topical corticosteroid
sleep disturbances
dermatitis
Investigational Site Number 8400001
 (3.9 away)
  • 0 views
  • 19 Feb, 2024
  • +41 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

nervous system disorders
genetic alteration
radiopharmaceutical therapy
graft versus host disease
131i-mibg
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +82 other locations
A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

The main purpose of this study is to evaluate the safety and tolerability of LY3372993 in participants with AD. The study will also investigate how much LY3372993 gets into the bloodstream and will test the effects of LY3372993. Participation could last up to about 54 weeks and may include up …

mini-mental state examination
alzheimer's disease
mental state examination
mild cognitive impairment
cognitive impairment
Collaborative Neuroscience Network - CNS
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations